March 04, 2015 7:50 AM ET

Capital Markets

Company Overview of Vulcan Capital

Executive Profile

Michael L. Kranda

Chief Executive Officer and Director, BEAT BioTherapeutics Corp.
AgeTotal Calculated CompensationThis person is connected to 3 Board Members in 3 different organizations across 5 different industries.

See Board Relationships
60--

Background

Mr. Michael L. Kranda serves as the Chief Executive Officer of BEAT BioTherapeutics Corp. Mr. Kranda served as the President and Chief Executive Officer at Vaccinogen, Inc. from September 2010 to June 2012. Mr. Kranda served as the Chief Executive Officer and President of Anesiva, Inc., since June 16, 2008. Mr. Kranda is a seasoned Biopharmaceutical Executive and has two decades of commercial operating and corporate development experience. Prior to Anesiva, Mr. Kranda ...

Corporate Headquarters

505 Fifth Avenue South
Seattle, Washington 98104

United States

Phone: 206-342-2000
Fax: 206-342-3000

Board Members Memberships

Former Director
Director
Former Chief Executive Officer, President and Director
Chief Executive Officer and Director
2002-N/A
Former Director
2003-Present
Director and Chairman of Audit Committee
2005-N/A
Chairman
2005-N/A
Former Director
2008-N/A
Former Chief Executive Officer, President and Director

Education

BA
University of Washington
MBA
University of Washington

Other Affiliations

Annual Compensation

There is no Annual Compensation data available.

Stocks Options

There is no Stock Options data available.

Total Compensation

There is no Total Compensation data available.
 

Stock Quotes

Market data is delayed at least 15 minutes.

Company Lookup

COMPETITOR COMPENSATION

There is no Competitor Compensation data available.

Sponsored Financial Commentaries

Sponsored Links

Report Data Issue

To contact Vulcan Capital, please visit . Company data is provided by Capital IQ. Please use this form to report any data issues.

Please enter your information in the following field(s):
Update Needed*

All data changes require verification from public sources. Please include the correct value or values and a source where we can verify.

Your requested update has been submitted

Our data partners will research the update request and update the information on this page if necessary. Research and follow-up could take several weeks. If you have questions, you can contact them at bwwebmaster@businessweek.com.